544184

New Filing detected. See link for details.

- Borosil Scientific Limited responded to BSE's query regarding an increase in its security's price/volume. - The company confirmed it has not withheld any material information/event that requires disclosure under SEBI regulations. - The increase in price/volume is attributed to market-driven factors.

- Intimation of Closure of Trading Window for Borosil Scientific Limited. - Trading window to remain closed for Designated Persons and their immediate relatives from July 01, 2026. - Closure is for the declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ending June 30, 2026. - The window will reopen 48 hours after the declaration of results.

Borosil Scientific Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms the company's full compliance with all applicable SEBI Regulations, including LODR, ICDR, SAST, and Insider Trading Regulations, and Secretarial Standards. It highlights no disqualification of directors, no resignation of statutory auditors, and no regulatory actions by SEBI or Stock Exchanges during the review period.

Borosil Scientific Limited's Nomination and Remuneration Committee approved the grant of 18,700 employee stock options on May 20, 2026. Each option, priced at ₹108 (approximately 10% discount to the market price), entitles the holder to one equity share of Re. 1/-. The options will vest 25% annually over four years from the grant date, with an exercise period of five years from vesting.